Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.62K Sell
20
-5
-20% -$698 ﹤0.01% 2198
2024
Q4
$3.43K Buy
25
+5
+25% +$687 ﹤0.01% 2128
2024
Q3
$2.03K Hold
20
﹤0.01% 2338
2024
Q2
$1.46K Buy
+20
New +$1.31K ﹤0.01% 2424
2023
Q2
Sell
-71
Closed -$2.87K 2710
2023
Q1
$2.87K Buy
71
+65
+1,083% +$2.55K ﹤0.01% 2092
2022
Q4
$221 Buy
+6
New +$211 ﹤0.01% 2716
2022
Q3
Sell
-276
Closed -$9.73K 2600
2022
Q2
$10K Buy
276
+73
+36% +$2.8K ﹤0.01% 1238
2022
Q1
$8K Buy
+203
New +$7.96K ﹤0.01% 1360

Other funds holding AGX

Lindbrook Capital's AGX Position: Q1 2025 in Review

Lindbrook Capital reduced its Argan (AGX) stake by 20% in Q1 2025, selling an estimated $698 and leaving 20 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Lindbrook Capital first reported a position in AGX in Q1 2022 and has held it in 8 quarters since. The position peaked at $10K in Q2 2022. 294 funds tracked by Wall St. Rank hold AGX as of Q1 2025.

  • Lindbrook Capital held 20 shares of Argan worth $2.62K as of Q1 2025.
  • Lindbrook Capital sold 5 Argan shares in Q1 2025, an estimated $698.
  • Argan made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2198 holding.
  • Lindbrook Capital first reported a position in Argan in Q1 2022 and has held it in 8 quarters since.
  • Lindbrook Capital's Argan position peaked at $10K in Q2 2022.
  • 294 funds tracked by Wall St. Rank held Argan as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.